Literature DB >> 16247664

Recurrent retroperitoneal malignant nerve sheath tumor associated with neurofibromatosis type 1 responding to carboplatin and etoposide combined chemotherapy.

Yoshiaki Kinebuchi1, Wataru Noguchi, Yasuhiko Igawa, Osamu Nishizawa.   

Abstract

A 25-year-old man was referred to our hospital with left flank pain, and computed tomography (CT) and magnetic resonance imaging (MRI) revealed large retroperitoneal masses. Physical examination revealed many café-au-lait spots and superficial neurofibromas, and a diagnosis of neurofibromatosis type 1 (von Recklinghausen's disease) was made. The tumor was resected, and the pathological diagnosis was malignant peripheral nerve sheath tumor (MPNST). Six months after the operation, lung metastases were detected. Surgical resection was incomplete, as there were too many lesions. He received four courses of chemotherapy with carboplatin and etoposide, and the metastatic lung lesions were markedly decreased. After chemotherapy, complete resection of the remaining lung lesions was performed, and there has been no recurrence to date.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247664     DOI: 10.1007/s10147-005-0495-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  7 in total

1.  Malignant peripheral nerve sheath tumor.

Authors:  Peter A Hrehorovich; Hubert R Franke; Suresh Maximin; Paula Caracta
Journal:  Radiographics       Date:  2003 May-Jun       Impact factor: 5.333

Review 2.  Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1.

Authors:  R M Reynolds; G G P Browning; I Nawroz; I W Campbell
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 3.  The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view.

Authors:  J Verweij; H T Mouridsen; O S Nielssen; P J Woll; R Somers; A T van Oosterom; M Van Glabbeke; T Tursz
Journal:  Crit Rev Oncol Hematol       Date:  1995-10       Impact factor: 6.312

Review 4.  Urologic manifestations of von Recklinghausen neurofibromatosis.

Authors:  M D Blum; R R Bahnson; M F Carter
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

5.  Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy.

Authors:  Martin B Steins; Hubert Serve; Michael Zühlsdorf; Norbert Senninger; Michael Semik; Wolfgang E Berdel
Journal:  Oncol Rep       Date:  2002 May-Jun       Impact factor: 3.906

6.  Recurrent malignant schwannoma of the parapharyngeal space in neurofibromatosis type 1.

Authors:  Andrea Gallo; Maria Suriano; Marilia Simonelli; Giovanni Ralli; Marco de Vincentiis
Journal:  Ear Nose Throat J       Date:  2003-11       Impact factor: 1.697

7.  Malignant peripheral nerve sheath tumor: analysis of treatment outcome.

Authors:  W W Wong; T Hirose; B W Scheithauer; S E Schild; L L Gunderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

  7 in total
  4 in total

1.  First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

Authors:  J R Kroep; M Ouali; H Gelderblom; A Le Cesne; T J A Dekker; M Van Glabbeke; P C W Hogendoorn; P Hohenberger
Journal:  Ann Oncol       Date:  2010-07-23       Impact factor: 32.976

2.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

3.  Malignant peripheral nerve sheath tumor of non-neurofibromatosis type I metastasized to the cerebrospinal axis.

Authors:  Man-Kyu Park; Joo-Kyung Sung; Kyung-Hun Nam; Kyoung-Tae Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-03-31

4.  Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.

Authors:  Matthias Kolberg; Maren Høland; Guro E Lind; Trude H Ågesen; Rolf I Skotheim; Kirsten Sundby Hall; Nils Mandahl; Sigbjørn Smeland; Fredrik Mertens; Ben Davidson; Ragnhild A Lothe
Journal:  Mol Oncol       Date:  2015-02-18       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.